Dr Reddys Laboratories Ltd Share Price Today - Live Blog for January 13, 2026

Dr Reddys Laboratories Ltd's share price has fallen by -2.06%, presenting both challenges and opportunities for investors. As of now, it's trading at 1190.50, and market participants are assessing the implications. The stock has a PE ratio of 17.6800, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has dropped by -2.06%, a development that warrants careful analysis. Presently trading at 1190.50, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd has experienced a -2.18% drop, and it's now trading at 1189.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd is facing a -1.99% decline and is currently trading at 1191.30 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -1.63% decrease in its share price, and it is currently trading at 1195.70. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.6800, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -1.22%, reaching a current market price of 1200.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.31% in its share price, and it currently trades at 1199.60 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.